You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 630 PD-L1/CD47 tumor directed B-BodyTM bispecific antibodies demonstrating significant anti-tumor activity with no toxicity in preclinical models

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immuno-conjugates and chimeric molecules
630 PD-L1/CD47 tumor directed B-BodyTM bispecific antibodies demonstrating significant anti-tumor activity with no toxicity in preclinical models

 

Online download statistics by month:

Online download statistics by month: November 2020 to September 2024

AbstractFullPdf
Nov 2020177020
Dec 2020128035
Jan 202146011
Feb 202182017
Mar 202178019
Apr 202192019
May 2021808
Jun 20210011
Jul 20211016
Aug 20210018
Sep 20210011
Oct 202162035
Nov 202168019
Dec 20212803
Jan 20222602
Feb 202246016
Mar 20221200
Apr 20225406
May 202256012
Jun 20224403
Jul 20222606
Aug 20223204
Sep 20227005
Oct 20224003
Nov 20224405
Dec 20221601
Jan 20232601
Feb 20231604
Mar 20231604
Apr 2023403
May 20231602
Jun 20233608
Jul 20231003
Aug 20231202
Sep 2023800
Oct 20231403
Nov 20232001
Dec 20232001
Jan 2024401
Feb 20241600
Mar 20242005
Apr 20242604
May 20241401
Jun 20245601
Jul 20245002
Aug 20241201
Sep 20241401
Total16460353